dr. fenske on the utility of next-generation btk inhibitors in mcl
Published 4 years ago • 105 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:41
dr. fenske on the future of daratumumab in mcl
-
1:30
dr. fenske discusses disease progression on ibrutinib in mcl
-
1:08
dr. fenske discusses targets under evaluation in mcl
-
0:41
dr. goy on the potential utility of btk inhibitors as maintenance in mcl
-
0:55
dr. smith on safety profiles of btk inhibitors in mcl
-
1:53
dr. fenske discusses ongoing study in frontline mcl
-
1:29
dr. wang on the benefit of btk inhibitors in mcl
-
1:47
dr. leslie on the role of btk inhibitors in relapsed/refractory mcl
-
4:03
mcl: fda approval of a second-generation btk inhibitor
-
1:21
dr koff on the role of covalent btk inhibitors and pirtobrutinib in mcl
-
59:49
rebooting the btk inhibitor sequence in mcl
-
1:32
selecting btk inhibitors for patients with mcl
-
1:16
dr. patel on differences between btk inhibitors in mcl
-
1:09
dr. cohen on the potential of btk inhibitors in frontline treatment of mcl
-
5:07
btk inhibitors in mcl: aes, specificity, and interactions
-
2:16
dr. ruan discusses btk inhibitors in mcl
-
4:13
mcl: novel btk inhibitor combination strategies
-
2:40
btk inhibitors for r/r mcl: current uses and insights from the vipor study
-
5:59
differentiating btk inhibitor mechanisms of action in mcl